Rockefeller University
ORCID: 0000-0002-8208-9154Publishes on Immunotherapy and Immune Responses, vaccines and immunoinformatics approaches, Viral-associated cancers and disorders. 176 papers and 1.8k citations.
Add your photo, update your bio, and get notified when your ranking changes.
Inositol pyrophosphates are a diverse group of high-energy signaling molecules whose cellular roles remain an active area of study. We report a previously uncharacterized class of inositol pyrophosphate synthase and find it is identical to yeast Vip1 and Asp1 proteins, regulators of actin-related protein-2/3 (ARP 2/3) complexes. Vip1 and Asp1 acted as enzymes that encode inositol hexakisphosphate (IP6) and inositol heptakisphosphate (IP7) kinase activities. Alterations in kinase activity led to defects in cell growth, morphology, and interactions with ARP complex members. The functionality of Asp1 and Vip1 may provide cells with increased signaling capacity through metabolism of IP6.
Eukaryotes possess numerous inositol phosphate (IP) and diphosphoinositol phosphate (PP-IPs or inositol pyrophosphates) species that act as chemical codes important for intracellular signaling pathways. Production of IP and PP-IP molecules occurs through several classes of evolutionarily conserved inositol phosphate kinases. Here we report the characterization of a human inositol hexakisphosphate (IP6) and diphosphoinositol pentakisphosphate (PP-IP5 or IP7) kinase with similarity to the yeast enzyme Vip1, a recently identified IP6/IP7 kinase (Mulugu, S., Bai, W., Fridy, P. C., Bastidas, R. J., Otto, J. C., Dollins, D. E., Haystead, T. A., Ribeiro, A. A., and York, J. D. (2007) Science 316, 106-109). Recombinant human VIP1 exhibits in vitro IP6 and IP7 kinase activities and restores IP7 synthesis when expressed in mutant yeast. Expression of human VIP1 in HEK293T cells engineered to produce high levels of IP7 results in dramatic increases in bisdiphosphoinositol tetrakisphosphate (PP2-IP4 or IP8). Northern blot analysis indicates that human VIP1 is expressed in a variety of tissues and is enriched in skeletal muscle, heart, and brain. The subcellular distribution of tagged human VIP1 is indicative of a cytoplasmic non-membrane localization pattern. We also characterized human and mouse VIP2, an additional gene product with nearly 90% similarity to VIP1 in the kinase domain, and observed both IP6 and IP7 kinase activities. Our data demonstrate that human VIP1 and VIP2 function as IP6 and IP7 kinases that act along with the IP6K/Kcs1-class of kinases to convert IP6 to IP8 in mammalian cells, a process that has been found to occur in response to various stimuli and signaling events.
We have characterized the positional specificity of the mammalian and yeast VIP/diphosphoinositol pentakisphosphate kinase (PPIP5K) family of inositol phosphate kinases. We deployed a microscale metal dye detection protocol coupled to a high performance liquid chromatography system that was calibrated with synthetic and biologically synthesized standards of inositol pyrophosphates. In addition, we have directly analyzed the structures of biological inositol pyrophosphates using two-dimensional 1H-1H and 1H-31P nuclear magnetic resonance spectroscopy. Using these tools, we have determined that the mammalian and yeast VIP/PPIP5K family phosphorylates the 1/3-position of the inositol ring in vitro and in vivo. For example, the VIP/PPIP5K enzymes convert inositol hexakisphosphate to 1/3-diphosphoinositol pentakisphosphate. The latter compound has in We have determined that the of the that synthesized and a the inositol hexakisphosphate kinase and VIP/PPIP5K the in the structures of inositol pyrophosphates. For example, in the the and to the of the that specificity in the and biological of inositol pyrophosphates. We have characterized the positional specificity of the mammalian and yeast VIP/diphosphoinositol pentakisphosphate kinase (PPIP5K) family of inositol phosphate kinases. We deployed a microscale metal dye detection protocol coupled to a high performance liquid chromatography system that was calibrated with synthetic and biologically synthesized standards of inositol pyrophosphates. In addition, we have directly analyzed the structures of biological inositol pyrophosphates using two-dimensional 1H-1H and 1H-31P nuclear magnetic resonance spectroscopy. Using these tools, we have determined that the mammalian and yeast VIP/PPIP5K family phosphorylates the 1/3-position of the inositol ring in vitro and in vivo. For example, the VIP/PPIP5K enzymes convert inositol hexakisphosphate to 1/3-diphosphoinositol pentakisphosphate. The latter compound has in We have determined that the of the that synthesized and a the inositol hexakisphosphate kinase and VIP/PPIP5K the in the structures of inositol pyrophosphates. For example, in the the and to the of the that specificity in the and biological of inositol pyrophosphates. a a of phosphate a The inositol ring the of to phosphate The in phosphate the inositol a family of of have The inositol pentakisphosphate high performance liquid inositol metal dye pentakisphosphate high performance liquid inositol metal dye and a of the family that the of a of phosphate and and The of inositol pyrophosphates biological in the of with the inositol to the of the inositol pyrophosphates to a the positional specificity of the and that these the of has the of the of the the of a of the and the inositol ring the pyrophosphates in have the the of phosphate the the phosphate to to of mammalian with synthetic standards that was the to that the enzymes that to of these enzymes in was and of these enzymes to of and two-dimensional these that the that a of enzymes of to a of The that kinase have in and in and to the VIP/PPIP5K family to a kinase that was in with and in yeast that yeast phosphorylates to a of that the the of was to of the of the was to the of a of the of a kinase in was to the of the of the The of has determined in these high of compound For example, two-dimensional was to that the in has the and the of the of of to the structures of inositol pyrophosphates in yeast and of these a the of in mammalian has the we have a protocol to the structures of the of the inositol pyrophosphates that in in in we to of two-dimensional We the that yeast and mammalian VIP/PPIP5K enzymes the that was in the VIP/PPIP5K to we that VIP/PPIP5K enzymes in with to that has the and of and and and and The of the in the of and standards was a of in and a was that of of and The was to with and the was The was in of and the of of of and to inositol pyrophosphates In of was of of and enzymes with of in of a that was to system and to and a of was with of the kinase of the kinase of these enzymes and The of and with to the of the was using kinase In a of was with of in and of the was and of was with of The was and the was a The was a and with the of was and The that inositol with and The was in of was using kinase and In a of was with of and of and in of using a with a and a and to and The of was a with a a a and a The using to a of The was a The and of the 1H-1H two-dimensional and of the 1H-31P two-dimensional The the with a of of a and a was a using a system with a to and of a of standards was in of and using in the with was and was and The was the was with of the of a in with and the of the was in a and with of standards and in to the of of the in the In the was the the was and and with of and was determined using liquid and of and in with in to with with and and in liquid the was and the with of the to with the was in a in to and inositol and inositol pyrophosphates and The in the of inositol pyrophosphates has to the structures of of For example, a of We have the protocol of chromatography a of and in a that phosphate a phosphate was that in was in the of the and in a the of was and a of and and these the system with synthesized standards of of these in and The the of For example, we that in of synthetic standards to the of a two-dimensional of to the of a of in synthetic to the of a synthesized of of to was has determined that the and VIP/PPIP5K enzymes in to was with and and in with the that was was has to with the that was was with yeast with a synthetic and in was to the that was in these and with of the a two-dimensional the that a of in yeast and The the of that characterized in the that we have the of the the to of these the positional specificity of yeast in we characterized the of the in enzymes in with For these we of the with The of to in and The to was In we with the of that was in that was the of to that the mammalian VIP/PPIP5K enzymes have the positional specificity yeast of the of VIP/PPIP5K and was with of in of of in of and analyzed using of standards was in to to and to and of the of and that of inositol to in We and and two-dimensional to the structures of the inositol pyrophosphates and the family and was a The of and in the to phosphate was and of the and to the of the inositol ring and The of the phosphate with the phosphate The of in phosphate and and and The that the the of that a The of phosphate and and and and positional and we to of and the of the of the of of the the of the of The the of The of a a and that The to the the inositol and to the that in The a and The the to and of the with that these and to the of and The with and and to the The with and with the of the to In the the and a of to and with the with the of in the and the to and of and with the and a with with the of a was the to the resonance with and of was two-dimensional 1H-1H The ring of the in was the of the with of the of the kinase with the the ring of the The of the a and and a The the and the and and the the the has the these to the of the inositol of the a and and The with the the the to to the has the and of the the inositol ring of and two-dimensional and the the and the The latter to the to and The in a with the two-dimensional 1H-31P to the to the the to the and the and to the the to a with the that the the The a to the to The to the and these the The a to the to The to the a the and with to the and that the the and The a to the to The to the and these the The to the a 1H-31P of and that the two-dimensional in the two-dimensional and of the In the and and of the of and the and the to a with and the to a and with and of the the and a with of the the of a with of the of the and the to a with The of the and of a in the of the of the the and a with of and of the and and the of and with of the the to a with of the the a with and the with and The and of the the and the to a with in the The of the and of a in of the of the and the and and to of the the to a of the the to a of the the to a The and in in in in in in a in in in in in in a in in in in in in a The of the in the of the the and to and the and The of the the and in the The of the and the and that the has the and to these was the of that a was of detection of the VIP/PPIP5K family and the in that the latter convert to a of the in vitro of in have to the of in mammalian to the specificity of the VIP/PPIP5K family that we have characterized in to inositol pyrophosphates in of of mammalian we of in inositol with of and We a to of inositol pyrophosphates to we with the that the inositol pyrophosphates the of with the of of was to the of of that with of of has in vivo. In the a to with with the in of the that we have to in vitro the VIP/PPIP5K of inositol phosphate of and in mammalian with and analyzed using of standards was in the of and the of and to and to the and and of to the of that synthesized of the that the inositol In the we a of the of the VIP/PPIP5K We that the yeast and mammalian VIP/PPIP5K to the of and in vivo. a of we that yeast and the of in of and the of in of The of in and that in mammalian and In the of the of in that of the mammalian inositol and inositol in has the in the that and that of a system of of inositol pyrophosphates to mammalian the in a of the in yeast and mammalian with a that directly in vitro the of the of and to of For example, of the the positional specificity of the and in The of the structures of inositol pyrophosphates in the the the VIP/PPIP5K The that the VIP/PPIP5K enzymes and the that to the of specificity the of the of a kinase that phosphate a to the of the of of inositol pyrophosphates and the of of the and of of to a of that the inositol pyrophosphates to a a of phosphate a The inositol ring the of to phosphate The in phosphate the inositol a family of of have The inositol pentakisphosphate high performance liquid inositol metal dye pentakisphosphate high performance liquid inositol metal dye and a of the family that the of a of phosphate and and The of inositol pyrophosphates biological in the of with the inositol to the of the inositol pyrophosphates to a the positional specificity of the and that these the of has the of the of the the of a of the and the inositol ring the pyrophosphates in have the the of phosphate the the phosphate to to In of mammalian with synthetic standards that was the to that the enzymes that to of these enzymes in was and of these enzymes to of and two-dimensional these that the that a of enzymes of to a of The that kinase have in and in and to the VIP/PPIP5K family to a kinase that was in with and in yeast that yeast phosphorylates to a of that the the of was to of the of the was to the of a of the of a kinase in was to the of the of the The of has determined in these high of compound For example, two-dimensional was to that the in has the and the of the of of to the structures of inositol pyrophosphates in yeast and of these a the of in mammalian has In the we have a protocol to the structures of the of the inositol pyrophosphates that in in in we to of two-dimensional We the that yeast and mammalian VIP/PPIP5K enzymes the that was in the VIP/PPIP5K to we that VIP/PPIP5K enzymes in with to that has the and of and and and and The of the in the of and standards was a of in and a was that of of and The was to with and the was The was in of and the of of of and to inositol pyrophosphates In of was of of and enzymes with of in of a that was to system and to and a of was with of the kinase of the kinase of these enzymes and The of and with to the of the was using kinase In a of was with of in and of the was and of was with of The was and the was a The was a and with the of was and The that inositol with and The was in of was using kinase and In a of was with of and of and in of using a with a and a and to and The of was a with a a a and a The using to a of The was a The and of the 1H-1H two-dimensional and of the 1H-31P two-dimensional The the with a of of a and a was a using a system with a to and of a of standards was in of and using in the with was and was and The was the was with of the of a in with and the of the was in a and with of standards and in to the of of the in the In the was the the was and and with of and was determined using liquid and of and in with in to with with and and in liquid the was and the with of the to with the was in a of and and and and The of the in the of and standards was a of in and a was that of of and The was to with and the was The was in of and the of of of and to inositol pyrophosphates In of was of of and enzymes with of in of a that was to system and to and In a of was with of the kinase of the kinase of these enzymes and The of and with to the of the was using kinase In a of was with of in and of the was and of was with of The was and the was a The was a and with the of was and The that inositol with and The was in of was using kinase and In a of was with of and of and in of using a with a and a and to and The of was a with a a a and a The using to a of The was a The and of the 1H-1H two-dimensional and of the 1H-31P two-dimensional The the with a of of a and a was a using a system with a to and of a of standards was in of and using in the with was and was and The was The the was with of the of a in with and the of the was in a and with of standards and in to the of of the in the In the was the the was and and with of and was determined using liquid and of and in with in to with with and and in liquid the was and the with of the to with the was in a in to and inositol and inositol pyrophosphates and The in the of inositol pyrophosphates has to the structures of of For example, a of We have the protocol of chromatography a of and in a that phosphate a phosphate was that in was in the of the and in a the of was and a of and and these the system with synthesized standards of of these in and The the of For example, we that in of synthetic standards to the of a two-dimensional of to the of a of in synthetic to the of a synthesized of of to was has determined that the and VIP/PPIP5K enzymes in to was with and and in with the that was was has to with the that was was with yeast with a synthetic and in was to the that was in these and with of the a two-dimensional the that a the positional specificity of yeast in we characterized the of the in enzymes in with For these we of the with The of to in and The to was In we with the of that was in that was the of to that the mammalian VIP/PPIP5K enzymes have the positional specificity yeast of the of VIP/PPIP5K and was with of in of of in of and analyzed using of standards was in to to and to and of the of and that of inositol to in We and and two-dimensional to the structures of the inositol pyrophosphates and the family and was a The of and in the to phosphate was and of the and to the of the inositol ring and The of the phosphate with the phosphate The of in phosphate and and and The that the the of that a The of phosphate and and and and positional and we to of and the of the of the of of the the of the of The the of The of a a and that The to the the inositol and to the that in The a and The the to and of the with that these and to the of and The with and and to the The with and with the of the to In the the and a of to and with the with the of in the and the to and of and with the and a with with the of a was the to the resonance with and of was two-dimensional 1H-1H The ring of the in was the of the with of the of the kinase with the the ring of the The of the a and and a The the and the and and the the the has the these to the of the inositol of the a and and The with the the the to to the has the and of the the inositol ring of and two-dimensional and the the and the The latter to the to and The in a with the two-dimensional 1H-31P to the to the the to the and the and to the the to a with the that the the The a to the to The to the and these the The a to the to The to the a the and with to the and that the the and The a to the to The to the and these the The to the a 1H-31P of and that the two-dimensional in the two-dimensional and of the In the and and of the of and the and the to a with and the to a and with and of the the and a with of the the of a with of the of the and the to a with The of the and of a in the of the of the the and a with of and of the and and the of and with of the the to a with of the the a with and the with and The and of the the and the to a with in the The of the and of a in of the of the and the and and to of the the to a of the the to a of the the to a The and in in in in in in a in in in in in in a in in in in in in a The of the in the of the the and to and the and The of the the and in the The of the and the and that the has the and to these was the of that a was of detection of the VIP/PPIP5K family and the in that the latter convert to a of the in vitro of in have to the of in mammalian to the specificity of the VIP/PPIP5K family that we have characterized in to inositol pyrophosphates in of of mammalian we of in inositol with of and We a to of inositol pyrophosphates to we with the that the inositol pyrophosphates the of with the of of was to the of of that with of of has in vivo. In the a to with with the in of the that we have to in vitro the VIP/PPIP5K of inositol phosphate of and in mammalian with and analyzed using of standards was in the of and the of and to and to the and and of to the of that synthesized of the that the inositol In the we a of the of the VIP/PPIP5K We that the yeast and mammalian VIP/PPIP5K to the of and in vivo. a of we that yeast and the of in of and the of in of The of in and that in mammalian and In the of the of in that of the mammalian inositol and inositol in has the in the that and that of a system of of inositol pyrophosphates to mammalian the in a of the in yeast and mammalian with a that directly in vitro the of the of and to of For example, of the the positional specificity of the and in The of the structures of inositol pyrophosphates in the the the VIP/PPIP5K The that the VIP/PPIP5K enzymes and the that to the of specificity the of the of a kinase that phosphate a to the of the of of inositol pyrophosphates and the of of the and of of to a of that the inositol pyrophosphates to in to and inositol and inositol pyrophosphates and The in the of inositol pyrophosphates has to the structures of of For example, a of We have the protocol of chromatography a of and in a that phosphate a phosphate was that in was in the of the and in a the of was and a of and and these the system with synthesized standards of of these in and The the of For example, we that in of synthetic standards to the of a two-dimensional of to the of a of in synthetic to the of a synthesized of of to was has determined that the and VIP/PPIP5K enzymes in to was with and and in with the that was was has to with the that was was with yeast with a synthetic and in was to the that was in these and with of the a two-dimensional the that a the positional specificity of yeast in we characterized the of the in enzymes in with For these we of the with The of to in and The to was In we with the of that was in that was the of to that the mammalian VIP/PPIP5K enzymes have the positional specificity yeast of the of and that of inositol to in We and and two-dimensional to the structures of the inositol pyrophosphates and the family and was a The of and in the to phosphate was and of the and to the of the inositol ring and The of the phosphate with the phosphate The of in phosphate and and and The that the the of that a The of phosphate and and and and positional and we to The of a a and that The to the the inositol and to the that in The a and The the to and of the with that these and to the of and The with and and to the The with and with the of the to In the the and a of to and with the with the of in the and the to and of the of the kinase with the the ring of the The of the a and and a The the and the and and the the the has the these to the of the inositol The of the a and and The with the the the to to the has the and The of the the inositol ring of and two-dimensional and the the and the The latter to the to and The in a with the two-dimensional 1H-31P to the to the the to the and the and to the the to a with the that the the The a to the to The to the and these the The a to the to The to the a the and with to the and that the the and The a to the to The to the and these the The to the a in the two-dimensional and of the In the and and of the of and the and the to a with and the to a and with and of the the and a with of the the of a with of the of the and the to a with The of the and of a in the of the of the the and a with of and of the and and the of and with of the the to a with of the the a with and In the with and The and of the the and the to a with in the The of the and of a in of the of the and the and and to of the the to a of the the to a of the the to a The and in The of the in the of the the and to and the and The of the the and in the The of the and the and that the has the and to these was the of that a was of detection of the VIP/PPIP5K family and the in that the latter convert to a of the in vitro of in have to the of in mammalian to the specificity of the VIP/PPIP5K family that we have characterized in to inositol pyrophosphates in of of mammalian we of in inositol with of and We a to of inositol pyrophosphates to we with the that the inositol pyrophosphates the of with the of of was to the of of that with of of has in vivo. In the a to with with the in of the that we have to in vitro the VIP/PPIP5K of inositol phosphate kinases. and of to the of that synthesized of the that the inositol In the we a of the of the VIP/PPIP5K We that the yeast and mammalian VIP/PPIP5K to the of and in vivo. a of we that yeast and the of in of and the of in of The of in and that in mammalian and In the of the of in that of the mammalian inositol and inositol in has the in the that and that of a system of of inositol pyrophosphates to mammalian the in a of the in yeast and mammalian with a that directly in vitro the of the of and to of For example, of the the positional specificity of the and in The of the structures of inositol pyrophosphates in the the the VIP/PPIP5K The that the VIP/PPIP5K enzymes and the that to the of specificity the of the of a kinase that phosphate a to the of the of of inositol pyrophosphates and the of of the and of of to a of that the inositol pyrophosphates to We and the of and with with